Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia areata is a common autoimmune disease affecting about 2% of people, causing significant disability and often associated with mental health issues and other autoimmune conditions.

Prolactin affects hair growth and skin conditions, and could be a target for new skin disease treatments.

Cannabinoids may help treat chronic and chemotherapy-induced neuropathic pain, but more research is needed to confirm their effectiveness and safety.

Despite progress in treatment, the exact cause of Alopecia areata is still unknown.

Skin doctors should know about skin and kidney disease links to prevent serious kidney problems.

The document concludes that autoimmune skin disorders are treated with corticosteroids and immunosuppressive drugs.

Early-onset AGA shows different hair and metabolic characteristics compared to normal-onset AGA.

Blue light might help treat skin conditions by affecting the skin's bacteria.

The article concludes that schoolchildren and adolescents experienced various skin issues during the COVID-19 pandemic, including acne from masks and other skin reactions from the virus and vaccines.

Athletes need effective management of skin disorders for their performance and well-being.

The document covers various dermatological treatments and conditions.

Baricitinib effectively improved both atopic dermatitis and alopecia areata symptoms in a patient.

A gene variant increases the risk of a type of hair loss by affecting hair protein production.

New treatments like nanotechnology show promise in improving skin cancer therapy.

Old neuropharmacological drugs might be effective for treating inflammatory skin diseases.

Light-based treatment, Photobiomodulation, shows promise for non-invasive skin therapy with few side effects.

The guidelines help doctors manage skin problems from certain cancer treatments to improve patients' lives.

Recognizing and managing central sensitization and stress is crucial for treating chronic pain.

Hair loss in men may be caused by inflammation triggered by hormones, and treatments reducing inflammation could potentially promote hair growth.

Tapinarof cream at 1% concentration is effective and better tolerated for treating atopic dermatitis than the 2% concentration.

Teriflunomide often causes mild to moderate hair thinning and loss in MS patients, which usually improves with or without treatment.

An intact skin barrier is crucial to prevent infection in cases of tether-induced tenosynovitis.

595 nm pulsed dye laser is a cost-effective treatment for nonmelanoma skin cancer with a low recurrence rate.

Using tacalcitol ointment with photodynamic therapy may effectively treat follicular mucinosis with scalp hair loss.

Skin changes can indicate starvation and nutritional deficiencies in anorexia nervosa.

Itch is a common symptom in patients with chronic venous insufficiency, often accompanied by burning and pain.

Itch is a common symptom in patients with chronic venous insufficiency, often worsening with standing or sitting and occurring mostly in the evening or at night.

Lysophosphatidic acid affects sensory neurons and may cause neuropathic pain and itch.

Diphencyprone treatment protocols could be simplified as no harm occurred despite not fully following them.

Mycophenolate mofetil improved skin condition in a man with nephrogenic fibrosing dermopathy.